Tsang; Kwok Yin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tsang; Kwok Yin.The latest application filed is for "ionizable compounds and compositions and uses thereof".

Company Profile

4.26.24

Tsang; Kwok Yin - Irvine CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Fusogenic compounds for delivery of biologically active molecules Grant 11,413,243 - Tsang , et al. August 16, 2	2022-08-16
Ionizable Compounds And Compositions And Uses Thereof App 20220242820 - Adami; Roger ; et al.	2022-08-04
Fusogenic Compounds For Delivery Of Biologically Active Molecules App 20220233445 - Tsang; Kwok Yin ; et al.	2022-07-28
Ionizable compounds and compositions and uses thereof Grant 11,384,051 - Adami , et al. July 12, 2	2022-07-12
Fusogenic compounds for delivery of biologically active molecules Grant 11,364,200 - Tsang , et al. June 21, 2	2022-06-21
Fusogenic compounds for delivery of biologically active molecules Grant 11,318,099 - Tsang , et al. May 3, 2	2022-05-03
RNA agents for P21 gene modulation Grant 10,405,749 - Minomi , et al. Sept	2019-09-10
Ionizable Compounds And Compositions And Uses Thereof App 20190127318 - Adami; Roger ; et al.	2019-05-02
Ionizable compounds and compositions and uses thereof Grant 10,167,253 - Adami , et al. J	2019-01-01
Polymer-based hydrotropes for hydrophobic drug delivery Grant 10,080,737 - Ying , et al. September 25, 2	2018-09-25
RNA interference agents for p21 gene modulation Grant 10,023,597 - Minomi , et al. July 17, 2	2018-07-17
Reduction of endotoxins from polyanionic polymer conjugates Grant 9,839,694 - Tsang , et al. December 12, 2	2017-12-12
Rna Interference Agents For P21 Gene Modulation App 20170298086 - Minomi; Kenjirou ; et al.	2017-10-19
RNA interference agents for P21 gene modulation Grant 9,695,206 - Minomi , et al. July 4, 2	2017-07-04
Large scale process for preparing poly (glutamyl-glutamate) conjugates Grant 9,636,411 - Bai , et al. May 2, 2	2017-05-02
Ionizable Compounds And Compositions And Uses Thereof App 20160376229 - Adami; Roger ; et al.	2016-12-29
Rna Agents For P21 Gene Modulation App 20160208255 - Niitsu; Yoshiro ; et al.	2016-07-21
Rna Interference Agents For P21 Gene Modulation App 20160208256 - Niitsu; Yoshiro ; et al.	2016-07-21
Co-polymer conjugates Grant 9,295,728 - Tsang , et al. March 29, 2	2016-03-29
A Large Scale Process For Preparing Poly (glutamyl-glutamate) Conjugates App 20160074524 - Bai; Hao ; et al.	2016-03-17
Reduction Of Endotoxins From Polyanionic Polymer Conjugates App 20160058877 - Tsang; Kwok Yin ; et al.	2016-03-03
Novel Polymer-based Hydrotropes For Hydrophobic Drug Delivery App 20150283253 - YING; Wenbin ; et al.	2015-10-08
Polymer conjugates with a linker Grant 9,078,926 - Nukui , et al. July 14, 2	2015-07-14
Polymer Conjugates With A Linker App 20130295039 - Nukui; Seiji ; et al.	2013-11-07
Co-polymer Conjugates App 20130272993 - Tsang; Kwok Yin ; et al.	2013-10-17
Stable Elsamitrucin Salt Formulations App 20110251143 - Gore; Ashok ; et al.	2011-10-13
Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same Grant 7,638,648 - Vasudevan , et al. December 29, 2	2009-12-29
Disubstituted chalcone oximes as selective agonists of RAR.sub..gamma. retinoid receptors Grant 7,476,673 - Tsang , et al. January 13, 2	2009-01-13
Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B Grant 7,468,391 - Vasudevan , et al. December 23, 2	2008-12-23
Disubstituted chalcone oximes having RAR.gamma. retinoid receptor antagonist activity Grant 7,432,388 - Tsang , et al. October 7, 2	2008-10-07
Disubstituted chalcone oximes having RARgamma retinoid receptor antagonist activity App 20080097119 - Tsang; Kwok Yin ; et al.	2008-04-24
4-[(8-substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-YL-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activity Grant 7,351,737 - Vasudevan , et al. April 1, 2	2008-04-01
Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same App 20080004455 - Vasudevan; Jayasree ; et al.	2008-01-03
Disubstituted chalcone oximes having RAR.gamma. retinoid receptor antagonist activity Grant 7,253,319 - Tsang , et al. August 7, 2	2007-08-07
Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same Grant 7,226,951 - Vasudevan , et al. June 5, 2	2007-06-05
5-[phenyl-tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl and heteroaryl-cyclopropyl]-pentadienoic acid derivatives having serum glucose reducing activity Grant 6,936,636 - Sinha , et al. August 30, 2	2005-08-30
Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B App 20050187298 - Vasudevan, Jayasree ; et al.	2005-08-25
Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same App 20050176689 - Vasudevan, Jayasree ; et al.	2005-08-11
Disubstituted chalcone oximes having RARy retinoid receptor antagonist activity App 20050165095 - Tsang, Kwok Yin ; et al.	2005-07-28
Disubstituted chalcone oximes as selective agonists of RAR retinoid receptors App 20050148590 - Tsang, Kwok Yin ; et al.	2005-07-07
7-[(7-alkoxy)-chrom-3-en-6-yl]-heptatrienoic Acid And 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic Acid Derivatives Having Serum Glucose Reducing Activity App 20050096380 - Beard, Richard L. ; et al.	2005-05-05
7-[(7-Alkoxy)-chrom-3-en-6-yl]-heptatrienoic acid and 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic acid derivatives having serum glucose reducing activity Grant 6,887,896 - Beard , et al. May 3, 2	2005-05-03
5-[phenyl-tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl and heteroaryl-cyclopropyl]-pentadienoic acid derivatives having serum glucose reducing activity App 20050004213 - Sinha, Santosh ; et al.	2005-01-06
4-[(8-ethynyl, 8-vinyl Or 8-ethynyl-methyl)-6-chromanoyl]-benzoic And 2-[4-[(8-ethynyl, 8-vinyl Or 8-ethynyl-methyl)-6-chromanoyl]-phenyl]-acetic Acid, Their Esters And Salts Having Cytochrome P450rai Inhibitory Activity Grant 6,740,676 - Vasudevan , et al. May 25, 2	2004-05-25
[3-(c5-14alkyl-2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-3-oxo-propenyl]-phen Yl And [3-(c5-14alkyl-2-oxo-1,2,3,4- Tetrahydro-quinolin-6-yl)-3-oxo-propenyl]-heteroaryl Derivatives Having Anti-tumor Activity Grant 6,683,092 - Tsang , et al. January 27, 2	2004-01-27
4-[(8-Substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-yl-ethyny- l]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activity App 20030207937 - Vasudevan, Jayasree ; et al.	2003-11-06
4-[(8-Ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-benzoic and 2-[4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-phenyl]-acet- ic acid, their esters and salts having cytochrome P450RAI inhibitory activity App 20030191181 - Vasudevan, Jayasree ; et al.	2003-10-09
2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors Grant 6,403,638 - Vuligonda , et al. June 11, 2	2002-06-11
2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors Grant 6,147,224 - Vuligonda , et al. November 14, 2	2000-11-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.